Linden LLC

Linden Welcomes René Lorenz as Operating Partner, Further Strengthening Pharma Services Focus

August 10, 2023 | For Immediate Release

Chicago, IL (August 8, 2023) – Linden Capital Partners, a Chicago-based private equity firm focused exclusively on healthcare, is pleased to announce the appointment of René Lorenz as an Operating Partner. Mr. Lorenz brings over 38 years of experience in the technology and biopharmaceutical services industries. Most recently, he served as the Chief Business Officer at IQVIA, where he was responsible for pricing strategies, strategic negotiations, business operations, and global sales.

As a key member of the executive leadership team at IQVIA, Mr. Lorenz served on the Executive Leadership Group for over 15 years. Prior to his tenure at IQVIA, he enjoyed a successful 23-year career at IBM (International Business Machines Corporation), where he held various senior leadership positions across sales, business operations, reseller channel, finance, and general management.

“Rene’s experience in commercial execution and strategy and understanding of the drug development landscape complements Linden’s longstanding pharma services sector focus,” said Linden Partner, Michael Farah. Mr. Lorenz commented, “I look forward to supporting Linden’s existing portfolio by seeking to optimize commercial execution and partnering on new investments to identify new opportunities to drive revenue.”

René Lorenz holds an Executive MBA in Finance and International Business from the Crummer School of Business at Rollins College and an undergraduate degree from Rollins College.

About Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on the healthcare industry. Founded in 2004, Linden is one of the country’s largest dedicated healthcare private equity firms. Linden’s strategy is based upon three elements: (i) healthcare specialization, (ii) integrated private equity and operating expertise, and (iii) its differentiated human capital program. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare. Since its founding, Linden has invested in over 40 healthcare companies encompassing over 250+ total transactions. The firm has raised over $7 billion in limited partner commitments since inception. For more information, please visit